Clincosm LogoSign in Get a demo

Multicenter Study of Tetanus Patients in Fujian Province of China

Sponsor
Fujian Provincial Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04165928
Collaborator
(none)
95
Enrollment
1
Location
16
Actual Duration (Months)
5.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Background: Tetanus is a life-threatening disease in developing countries, and accompanied by a high mortality rate. China is the world's largest developing country, and Fujian Province is a typical coastal province in China with a relatively developed economy. Therefore, the purpose of this study was to investigate the epidemiology, incidence and management of tetanus in Fujian Province and to understand the current treatment and prognosis of tetanus patients in China.

Methods: This was a retrospective multicenter observational study of patients who presented with a clinical diagnosis of tetanus at 5 general hospitals in Fujian. Data was analyzed using computer software system.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    95 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Multicenter Study of Tetanus Patients in Fujian Province of China
    Actual Study Start Date :
    Jul 1, 2018
    Actual Primary Completion Date :
    Sep 30, 2019
    Actual Study Completion Date :
    Oct 31, 2019

    Outcome Measures

    Primary Outcome Measures

    1. Outcomes of the tetanus patients [2008-01-01~2018-10-31]

      The survival data of tetanus patients.

    Secondary Outcome Measures

    1. The hospitalization time. [2008-01-01~2018-10-31]

      The total length of hospitalization and the length of stay in the ICU.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • This study included all patients of all age groups and both sexes who presented with a clinical diagnosis of tetanus.
    Exclusion Criteria:
    • None.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fujian Provincial Hospital Fuzhou Fujian China 350000

    Sponsors and Collaborators

    • Fujian Provincial Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Xiuling Shang, Deputy Director of the Physician, Fujian Provincial Hospital
    ClinicalTrials.gov Identifier:
    NCT04165928
    Other Study ID Numbers:
    • K2018-09-005
    First Posted:
    Nov 18, 2019
    Last Update Posted:
    Nov 18, 2019
    Last Verified:
    Nov 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Xiuling Shang, Deputy Director of the Physician, Fujian Provincial Hospital
    neonatal tetanus
    tetanus immunization program
    drug-induced
    tetanus antitoxin
    critical care medicine
    artificial airway
    Additional relevant MeSH terms:
    Tetanus
    Tetany

    Study Results

    No Results Posted as of Nov 18, 2019